Both in Pharmaceuticals
Royalty Pharma vs Viatris
Over the past year RPRX returned +79.0% and VTRS returned +83.7%; their daily moves had a correlation of 0.33.
RPRX +79.0% VTRS +83.7%Growth of $1, one year, split-adjusted
| Metric | RPRX | VTRS |
|---|---|---|
| Price | $67.18 | $19.04 |
| Market cap | $29.91B | $21.86B |
| Today | +1.90% | −0.86% |
| 1 month | +16.6% | +9.0% |
| 6 months | +35.8% | +26.6% |
| Year to date | +73.9% | +52.9% |
| 1 year | +83.2% | +85.3% |
| Revenue growth (YoY) | +16.5% | +4.9% |
| Gross margin | 100.0% | 38.8% |
| Net margin | 2.7% | −3.2% |
| P/E (TTM) | 36.7× | — |
| Price / sales | 11.8× | 1.5× |
| Net cash | -$8.23B | -$12.46B |
| Dividend yield | 1.40% | 2.52% |
| Volatility (60d) | 24.9% | 22.9% |
| Short % of float | 2.9% | 3.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).